Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  HIV Infection

  Free Subscription


02.05.2022

6 AIDS
2 AIDS Res Hum Retroviruses
8 Antivir Ther
1 BMC Neurol
1 Cell
6 Clin Infect Dis
1 HIV Med
5 J Acquir Immune Defic Syndr
2 J Infect Dis
1 J Med Virol
2 J Virol
2 PLoS Comput Biol
2 PLoS One
1 PLoS Pathog
1 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. WONG NS, Wong BCK, Chan JMC, Wong KH, et al
    Surrogate neutralisation responses following SARS-CoV-2 vaccination in people living with HIV - comparison between inactivated and mRNA vaccine.
    AIDS. 2022 Apr 23. pii: 00002030-990000000-00010.
    PubMed         Abstract available

  2. KAZEMIAN P, Ding DD, Scott JA, Feser MK, et al
    The cost-effectiveness of a resilience-based psychosocial intervention for HIV prevention among men who have sex with men in India.
    AIDS. 2022 Apr 26. pii: 00002030-990000000-00012.
    PubMed         Abstract available

  3. TETENS MM, Gerstoft J, Kronborg G, Johansen IS, et al
    Risk of subarachnoid haemorrhages and aneurysms in Danish People Living With HIV, a nationwide cohort study.
    AIDS. 2022 Apr 27. pii: 00002030-990000000-00014.
    PubMed         Abstract available

  4. AUNG HL, Gates TM, Mao L, Brew BJ, et al
    Abnormal cognitive aging in people with HIV: Evidence from Data Integration between two countries' cohort studies.
    AIDS. 2022 Apr 27. pii: 00002030-990000000-00013.
    PubMed         Abstract available

  5. SAX PE, Andreatta K, Molina JM, Daar ES, et al
    High Efficacy of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with Suppressed HIV and Preexisting M184 V/I.
    AIDS. 2022 Apr 23. pii: 00002030-990000000-00011.
    PubMed         Abstract available

  6. VOGT SL, Maloma L, Xian RR, Ambinder RF, et al
    Significance of lymph node fine needle aspiration for the diagnosis of HIV-associated lymphoma in a low-resource setting.
    AIDS. 2022 Apr 23. pii: 00002030-990000000-00009.
    PubMed         Abstract available


    AIDS Res Hum Retroviruses

  7. NARVAEZ M, Lins-Kusterer L, Valdelamar-Jimenez J, Brites C, et al
    Quality of life and antiretroviral therapy adherence: A cross-sectional study in Colombia.
    AIDS Res Hum Retroviruses. 2022 Apr 22. doi: 10.1089/AID.2021.0233.
    PubMed         Abstract available

  8. FERGUSON N, Cogswell A, Barker E
    Contribution of Innate Lymphoid Cells in Supplementing Cytokines Produced by CD4+ T-cells During Acute and Chronic SIV Infection of the Colon.
    AIDS Res Hum Retroviruses. 2022 Apr 22. doi: 10.1089/AID.2022.0007.
    PubMed         Abstract available


    Antivir Ther

  9. MOLINA JM, Ene L, Cahn P, Fatkenheuer G, et al
    Long-term safety and efficacy of rilpivirine in combination with nucleoside/nucleotide reverse transcriptase inhibitors in HIV-1 infected patients: 336-week rollover study of phase 2b and 3 clinical studies.
    Antivir Ther. 2021;26.
    PubMed         Abstract available

  10. RIVERA AS, Machenry S, Okpokwu J, Olatunde B, et al
    HBV co-infection is associated with persistently elevated liver stiffness measurement in HIV-positive adults: A 6-year single-centre cohort study in Nigeria.
    Antivir Ther. 2021;26.
    PubMed         Abstract available

  11. PRESSIAT C, Dainguy E, Treluyer JM, Yonaba C, et al
    Comparison of three galenic forms of lamivudine in young West African children living with Human Immunodeficiency Virus.
    Antivir Ther. 2021;26.
    PubMed         Abstract available

  12. MAGGIOLO F, Gianotti N, Comi L, Di Filippo E, et al
    Rilpivirine plus cobicistat-boosted darunavir as alternative to standard three-drug therapy in HIV-infected, virologically suppressed subjects: Final results of the PROBE 2 trial.
    Antivir Ther. 2021;26.
    PubMed         Abstract available

  13. SCHEIBE K, Urbanska A, Jakubowski P, Hlebowicz M, et al
    Low prevalence of doravirine-associated resistance mutations among polish human immunodeficiency-1 (HIV-1)-infected patients.
    Antivir Ther. 2021;26.
    PubMed         Abstract available

  14. FARINACCI D, Ciccullo A, Lombardi F, Moschese D, et al
    Evaluation of doravirine-based regimen population target in a large Italian clinical center.
    Antivir Ther. 2021;26.
    PubMed         Abstract available

  15. CICCULLO A, Baldin G, Borghetti A, Di Giambenedetto S, et al
    Real-life findings on the impact of the COVID-19 pandemic on HIV care.
    Antivir Ther. 2021;26.
    PubMed        

  16. KOUAME GM, Gabillard D, Moh R, Badje A, et al
    Higher risk of mortality in HIV-HBV co-infected patients from sub-Saharan Africa is observed at lower CD4(+) cell counts.
    Antivir Ther. 2021;26.
    PubMed         Abstract available


    BMC Neurol

  17. PATEL P, Shah D, Jani C, Shah J, et al
    Outcomes of patients presenting with Guillain-Barre Syndrome at a tertiary care center in India.
    BMC Neurol. 2022;22:151.
    PubMed         Abstract available


    Cell

  18. QU L, Yi Z, Shen Y, Lin L, et al
    Circular RNA vaccines against SARS-CoV-2 and emerging variants.
    Cell. 2022 Apr 1. pii: S0092-8674(22)00394-4. doi: 10.1016/j.cell.2022.
    PubMed         Abstract available


    Clin Infect Dis

  19. GARCIA-CREMADES M, Vucicevic K, Hendrix CW, Jayachandran P, et al
    Characterizing HIV-preventive, plasma tenofovir concentrations. A pooled participant-level data analysis from HIV pre-exposure prophylaxis (PrEP) clinical trials.
    Clin Infect Dis. 2022 Apr 26. pii: 6574602. doi: 10.1093.
    PubMed         Abstract available

  20. CAMPBELL JR, Chan ED, Falzon D, Trajman A, et al
    Low Body Mass Index at Treatment Initiation and Rifampicin-Resistant Tuberculosis Treatment Outcomes: An Individual Participant Data Meta-Analysis.
    Clin Infect Dis. 2022 Apr 27. pii: 6574751. doi: 10.1093.
    PubMed         Abstract available

  21. NGUYEN H, Hampel B, Nunez DG, Battegay M, et al
    Correction to: Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group.
    Clin Infect Dis. 2022 Apr 27. pii: 6575499. doi: 10.1093.
    PubMed        

  22. YOUNG MR, Broadwell C, Kacanek D, Chadwick EG, et al
    Sexually transmitted infections in pregnant people living with HIV: Temporal trends, demographic correlates and association with preterm birth.
    Clin Infect Dis. 2022 Apr 29. pii: 6576157. doi: 10.1093.
    PubMed         Abstract available

  23. PODELL BK, Aibana O, Huang CC, DiLisio JE, et al
    The Impact of Vitamin A Deficiency on Tuberculosis Progression.
    Clin Infect Dis. 2022 Apr 29. pii: 6576158. doi: 10.1093.
    PubMed         Abstract available

  24. SEIDMAN D, Logan R, Weber S, Gandhi A, et al
    Reimagining Preexposure Prophylaxis Provision for Women in the United States.
    Clin Infect Dis. 2022 Apr 28. pii: 6432205. doi: 10.1093.
    PubMed         Abstract available


    HIV Med

  25. BONJOCH A, Juega J, Echeverria P, Puig J, et al
    Prevalence, progression, and management of advanced chronic kidney disease in a cohort of people living with HIV.
    HIV Med. 2022 Apr 26. doi: 10.1111/hiv.13317.
    PubMed         Abstract available


    J Acquir Immune Defic Syndr

  26. SCHROTER J, Anelone AJN, de Boer RJ
    Quantification of CD4 Recovery in Early-Treated Infants Living With HIV.
    J Acquir Immune Defic Syndr. 2022;89:546-557.
    PubMed         Abstract available

  27. CANNON CA, Ramchandani MS, Buskin S, Dombrowski J, et al
    Previous Pre-Exposure Prophylaxis Use Among Men Who Have Sex with Men Newly Diagnosed with HIV Infection in King County, Washington.
    J Acquir Immune Defic Syndr. 2022 Apr 29. pii: 00126334-990000000-00035.
    PubMed         Abstract available

  28. KWAPONG YA, Sharma G, Shade JK, Piggott DA, et al
    Effect of HIV Serostatus on ICU Admission and Mortality among Hospitalized Coronavirus Disease 2019 (COVID-19) Patients.
    J Acquir Immune Defic Syndr. 2022 Apr 28. pii: 00126334-990000000-00031.
    PubMed        

  29. JOHNSTON CD, Siegler EL, Rice MC, Derry-Vick HM, et al
    Plasma Cell-Free Mitochondrial DNA as a Marker of Geriatric Syndromes in Older Adults with HIV.
    J Acquir Immune Defic Syndr. 2022 Apr 26. pii: 00126334-990000000-00029.
    PubMed         Abstract available

  30. ZEWDIE K, Kiptinness C, Ngure K, Kipkurui N, et al
    Targeted implementation of HIV self-testing increases testing uptake among partners of index persons known to have HIV in Kenya.
    J Acquir Immune Defic Syndr. 2022 Apr 27. pii: 00126334-990000000-00030.
    PubMed         Abstract available


    J Infect Dis

  31. CHAUDRON SE, Leemann C, Kusejko K, Nguyen H, et al
    A systematic molecular epidemiology screen reveals numerous HIV-1 superinfections in the Swiss HIV Cohort Study.
    J Infect Dis. 2022 Apr 29. pii: 6575836. doi: 10.1093.
    PubMed         Abstract available

  32. PETERSEN KJ, Strain J, Cooley S, Vaida F, et al
    Machine learning quantifies accelerated white-matter aging in persons with HIV.
    J Infect Dis. 2022 Apr 28. pii: 6575226. doi: 10.1093.
    PubMed         Abstract available


    J Med Virol

  33. LI Y, Wang X, Jin J, Ma Z, et al
    T cell responses to SARS-CoV-2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine.
    J Med Virol. 2022 Apr 26. doi: 10.1002/jmv.27814.
    PubMed         Abstract available


    J Virol

  34. CIENIEWICZ B, Kirillov V, Daher I, Li X, et al
    IKKalpha-Mediated Noncanonical NF-kappaB Signaling Is Required To Support Murine Gammaherpesvirus 68 Latency In Vivo.
    J Virol. 2022 Apr 28:e0002722. doi: 10.1128/jvi.00027.
    PubMed         Abstract available

  35. CHIKATA T, Paes W, Kuse N, Partridge T, et al
    Impact of Micropolymorphism Outside the Peptide Binding Groove in the Clinically Relevant Allele HLA-C*14 on T Cell Responses in HIV-1 Infection.
    J Virol. 2022 Apr 27:e0043222. doi: 10.1128/jvi.00432.
    PubMed         Abstract available


    PLoS Comput Biol

  36. HOEHN KB, Pybus OG, Kleinstein SH
    Phylogenetic analysis of migration, differentiation, and class switching in B cells.
    PLoS Comput Biol. 2022;18:e1009885.
    PubMed         Abstract available

  37. KUMATA R, Iwanami S, Mar KB, Kakizoe Y, et al
    Antithetic effect of interferon-alpha on cell-free and cell-to-cell HIV-1 infection.
    PLoS Comput Biol. 2022;18:e1010053.
    PubMed         Abstract available


    PLoS One

  38. MABUNDA N, Augusto O, Zicai AF, Duaja A, et al
    Nucleic acid testing identifies high prevalence of blood borne viruses among approved blood donors in Mozambique.
    PLoS One. 2022;17:e0267472.
    PubMed         Abstract available

  39. LU MD, Telwatte S, Kumar N, Ferreira F, et al
    Novel assays to investigate the mechanisms of latent infection with HIV-2.
    PLoS One. 2022;17:e0267402.
    PubMed         Abstract available


    PLoS Pathog

  40. HINGANKAR N, Deshpande S, Das P, Rizvi ZA, et al
    A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant.
    PLoS Pathog. 2022;18:e1010465.
    PubMed         Abstract available


    Vaccine

  41. PERCIACCANTE A, Asensi V, Cucu AI, Charlier P, et al
    War, pandemic and vaccination - Upcoming health problems by the refugee wave in Europe?
    Vaccine. 2022 Apr 23. pii: S0264-410X(22)00465.
    PubMed        


    Virology

  42. RAI M, Timilsina U, Gaur R
    Construction and characterization of a full-length, replication-competent and infectious enhanced green fluorescence protein-tagged HIV-1 subtype C molecular clone.
    Virology. 2022;571:34-38.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: